SDG&E unveils four advanced microgrids in San Diego that enhance grid resilience and utilize remote management to maintain power during outages and peak demand times.

Engineers from San Diego State University and USC design 3D-printed protective gear inspired by cuttlefish bones for athletes, service members, and astronauts.

The University of California San Diego developed an AI tool, COMPOSER, that successfully predicts sepsis, leading to a 17% reduction in related mortality rates.

Atmospheric chemist Kimberly Prather from UC San Diego wins the 2024 NAS Award in Chemical Sciences for her work on atmospheric aerosols' effects on climate, air quality, and health.

UC San Diego scientists developed an AI that predicts tumor responses to chemotherapy, potentially improving cervical cancer treatment by assessing genetic mutations en masse.

Limmi has launched an AI-powered Disease Insights Platform to improve early disease detection and management, initially focusing on predicting kidney stone recurrence in collaboration with UC San Diego Health.

Scientists at UC San Diego have created a noninvasive test to improve IVF, analyzing exRNAs in embryos' culture media to identify quality embryos, potentially increasing success rates.

Proteome Sciences has opened a new laboratory in San Diego to serve the biotech hub with advanced mass spectrometry technologies, supporting local pharmaceutical and academic research.

UC San Diego researchers developed a vaccine targeting an enzyme variant related to acne, potentially offering a more targeted treatment without harming beneficial skin bacteria.

Illumina plans to divest its cancer detection spinoff GRAIL by Q2 2024 following antitrust rulings and regulatory pressure, as detailed in its press release.

Airbnb is using AI to prevent disruptive New Year's Eve parties, with the technology screening high-risk bookings in various countries, including the US and UK, to ensure neighborhoods remain peaceful.

UCSD researchers have identified blood biomarkers signaling suicidal thoughts in individuals with depression, potentially impacting mental health treatment.

Innovative IBD diagnosis and treatment breakthrough using reverse metabolomics.